A Kolliakou1, M Ball2, L Derczynski3, D Chandran2, G Gkotsis2, P Deluca4, R Jackson5, H Shetty6, R Stewart2. 1. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: anna.kolliakou@kcl.ac.uk. 2. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 3. Department of Computer Science, University of Sheffield, Sheffield, UK. 4. National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 5. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 6. NIHR Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK.
Abstract
BACKGROUND: Public health monitoring is commonly undertaken in social media but has never been combined with data analysis from electronic health records. This study aimed to investigate the relationship between the emergence of novel psychoactive substances (NPS) in social media and their appearance in a large mental health database. METHODS: Insufficient numbers of mentions of other NPS in case records meant that the study focused on mephedrone. Data were extracted on the number of mephedrone (i) references in the clinical record at the South London and Maudsley NHS Trust, London, UK, (ii) mentions in Twitter, (iii) related searches in Google and (iv) visits in Wikipedia. The characteristics of current mephedrone users in the clinical record were also established. RESULTS: Increased activity related to mephedrone searches in Google and visits in Wikipedia preceded a peak in mephedrone-related references in the clinical record followed by a spike in the other 3 data sources in early 2010, when mephedrone was assigned a 'class B' status. Features of current mephedrone users widely matched those from community studies. CONCLUSIONS: Combined analysis of information from social media and data from mental health records may assist public health and clinical surveillance for certain substance-related events of interest. There exists potential for early warning systems for health-care practitioners.
BACKGROUND: Public health monitoring is commonly undertaken in social media but has never been combined with data analysis from electronic health records. This study aimed to investigate the relationship between the emergence of novel psychoactive substances (NPS) in social media and their appearance in a large mental health database. METHODS: Insufficient numbers of mentions of other NPS in case records meant that the study focused on mephedrone. Data were extracted on the number of mephedrone (i) references in the clinical record at the South London and Maudsley NHS Trust, London, UK, (ii) mentions in Twitter, (iii) related searches in Google and (iv) visits in Wikipedia. The characteristics of current mephedrone users in the clinical record were also established. RESULTS: Increased activity related to mephedrone searches in Google and visits in Wikipedia preceded a peak in mephedrone-related references in the clinical record followed by a spike in the other 3 data sources in early 2010, when mephedrone was assigned a 'class B' status. Features of current mephedrone users widely matched those from community studies. CONCLUSIONS: Combined analysis of information from social media and data from mental health records may assist public health and clinical surveillance for certain substance-related events of interest. There exists potential for early warning systems for health-care practitioners.
Authors: Miguel Angel Alvarez-Mon; María Llavero-Valero; Angel Asunsolo Del Barco; Melchor Alvarez-Mon; Rodrigo Sánchez-Bayona; Victor Pereira-Sanchez; Maria Vallejo-Valdivielso; Jorge Monserrat; Guillermo Lahera Journal: J Med Internet Res Date: 2019-05-28 Impact factor: 5.428
Authors: Anna Kolliakou; Ioannis Bakolis; David Chandran; Leon Derczynski; Nomi Werbeloff; David P J Osborn; Kalina Bontcheva; Robert Stewart Journal: Sci Rep Date: 2020-02-06 Impact factor: 4.379
Authors: Marissa Bartmess; Catherine Talbot; Siobhan T O'Dwyer; Ruth Palan Lopez; Karen M Rose; Joel G Anderson Journal: Dementia (London) Date: 2022-05-13